Sun Pharma Advanced Research Company Ltd Share Price
Last Updated Date: 27 Aug 2026
₹194.75
+0.25 (+0.13%)
As of 28 Aug 2026, Sun Pharma Advanced Research Company Ltd share price is ₹194.75. The stock opened at ₹194.75 and had closed at ₹194.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹108.20 and a high of ₹289.00. In terms of performance, Sun Pharma Advanced Research Company Ltd share price has increased by 48.93% over the past six months and has increased by 38.78% over the last year.
SPARC Charts
Sun Pharma Advanced Research Company Ltd Overview
Market cap₹6,312 Crs
Volume70,823
Prev. Close₹194.50
Year range₹108.20 - ₹289.00
Total Value₹1,37,92,779.25
ISININE232I01014
About SPARC
Sun Pharma Advanced Research Company is engaged in the business of research and development (R&D) of pharmaceutical products.
Sun Pharma Advanced Research Company Ltd Historical Performance
1 Month Return-9.49%
6 Month Return51.83%
3 Year Return-11.39%
3 Month Return-17.15%
1 Year Return36.16%
5 Year Return-35.17%
Sun Pharma Advanced Research Company Ltd Fundamental Analysis
ROCE(TTM)81.08%
P/E Ratio (TTM)3.99
P/B Ratio4.73
Debt to Equity0.42
ROE116.39%
EPS (TTM)49.17
Dividend Yield0.00%
Book Value41.09
Profit Margin2298.06%
Operating Margin84.12%
Sun Pharma Advanced Research Company Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 63.58 | 1,855.02 | 8.45 | 7.87 | 18.66 |
| EBITDA | -10.65 | 1,774.74 | -69.23 | -65.88 | -43.31 |
| Net Profit | -20.98 | 1,760.70 | -80.57 | -75.97 | -52.03 |
| EPS | -0.65 | 54.26 | -2.48 | -2.34 | -1.60 |
Sun Pharma Advanced Research Company Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 35.92 |
| MACD | -7.67 |
| 20-Day SMA | 202.98 |
Sun Pharma Advanced Research Company Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Sun Pharma Advanced Research Company Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Sun Pharma Advanced Research Company Ltd today is ₹194.75 on NSE and ₹194.75 on BSE.
- The 52-week high of Sun Pharma Advanced Research Company Ltd is ₹289.00, while the 52-week low is ₹108.20.
- The current market capitalisation of Sun Pharma Advanced Research Company Ltd is approximately ₹6,312 crore.
- The P/E (Price-to-Earnings) ratio of Sun Pharma Advanced Research Company Ltd is -14.95. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Sun Pharma Advanced Research Company Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Sun Pharma Advanced Research Company Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Sun Pharma Advanced Research Company Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Sun Pharma Advanced Research Company Ltd has delivered a return of approximately -11.39%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Sun Pharma Advanced Research Company Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 65.67% promoters, 3.82% FIIs, 0.09% DIIs, and 18.57% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
